TITLE

Long-term and short-term oral anticoagulation therapies were equivalent for venous thromboembolism

AUTHOR(S)
Kearon, Clive
PUB. DATE
January 2002
SOURCE
ACP Journal Club;Jan/Feb2002, Vol. 136 Issue 1, p10
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the study 'Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf Deep Vein Thrombosis,' by L. Pinede, J. Ninet, P. Duhaut, et al., published on the May 22, 2001 issue of the 'Circulation' journal. Comment on the study.
ACCESSION #
8866198

 

Related Articles

  • 3 months and 1 year of oral anticoagulant therapy were equivalent for idiopathic proximal deep venous thrombosis.  // ACP Journal Club;Jan/Feb2002, Vol. 136 Issue 1, p11 

    Presents an abstract of the study 'Three Months Versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis,' by G. Agnelli, P. Prandoni, M. G. Santamaria, et. al., and the Warfarin Optimal Duration Italian Trial Investigators, published on the July 19, 2001 issue of the...

  • Rare presentation of pial arteriovenous malformations as proptosis: Case report and review of literature. Saligoudar, Praveen; Seshadri, Roopa; Pandey, Paritosh // Neurology India;Mar/Apr2013, Vol. 61 Issue 2, p200 

    The article presents a case study describing a 35-year old patient developing a rare ocular symptoms and proptosis of pial arteriovenous malformations (AVMs). The patient had partial embolization of the AVM due to progressive protrusion and redness of left eye with dilated episcleral vessels and...

  • Subclinical Stroke in AF Ablation. DiMarco, John P. // Clinical Cardiology Alert;Oct2011, Vol. 30 Issue 10, p76 

    The author discusses a study by C. H. Siklody and colleagues which concluded that pulmonary vein isolation applied with the multielectrode duty-cycled phased radiofrequency (RF) ablation catheter are associated with increased incidence of subclinical intracranial emboli. He states, based on the...

  • Pulmonary vein thrombosis after bilobectomy and development of collateral circulation. Genta P R; Ho N; Beyruti R; Takagaki T Yae; Terra-Filho M // Thorax;Jun2003, Vol. 58 Issue 6, p550 

    Pulmonary vein thrombosis is a rare but potentially life threatening complication following lobectomy or bilobectomy. We present a case of right upper pulmonary vein thrombosis after a middle and lower lobectomy diagnosed at transoesophageal echocardiography. The patient was treated with...

  • A MOUSE MINUS CLOTTING FACTOR GENE. Kingman, Sharon // BioWorld Today;2/11/2014, Vol. 25 Issue 28, p9 

    The article focuses on the anticoagulation therapy experiments using the antibody 3F7 developed in 2005 by Swedish, Australian and German researchers. The study showed that mice which were manipulated genetically to block the clotting factor XII were protected from the development of thrombosis....

  • Malignancies increased risk for non-leg DVT.  // Hem/Onc Today;6/25/2014, Vol. 15 Issue 12, p42 

    The article discusses the results of a nested prospective cohort study which appeared in an article by F. Lamontagne in a 2014 issue of the "Journal of the American Medical Association (JAMA) Internal Medicine," showing the low adherence with guidelines on a suggested course of therapeutic...

  • ticlopidine.  // Royal Society of Medicine: Medicines;2002, p534 

    This article presents information on ticlopidine, an antiplatelet drug which is used to prevent thrombosis, but does not have an anticoagulant action. It works by stopping platelets sticking to one another or to the walls of blood vessels. It is used to reduce complications in patients with...

  • tirofiban.  // Royal Society of Medicine: Medicines;2002, p536 

    This article provides information on tirofiban which can be used to prevent thrombosis or blood-clot formation. The antithrombic drug works by stopping platelets sticking to one another or to the walls of blood vessels. It can be used together with heparin and aspirin to prevent thrombosis in...

  • Profilaktyka i leczenie powik³añ zakrzepowo-zatorowych u pacjentów z zaawansowan¹ chorob¹ nowotworow¹. Deskur-Śmielecka, Ewa; Kotlińska-Lemieszek, Aleksandra; Bączyk, Ewa; Gorzelińska, Lidia; Sopata, Maciej // Palliative Medicine / Medycyna Paliatywna;2013, Issue 1, p8 

    Venous thromboembolism (VT) is a common problem in patients with advanced cancer, worsening the prognosis and quality of life.However, prophylaxis and treatment of VT in this population is controversial because of high risk of bleeding and shortage of evidence supporting such management. The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics